Form 4 for NSPR InspireMD, Inc.
Accepted 2024-01-25 00:00:00 ET · period of report 2024-01-23 · accession 0001493152-24-003773 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-25 | 2024-01-23 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +563.5K | 1.85M | +44% | $0 |
| D | 2024-01-25 | 2024-01-23 | NSPR | Slosman Marvin | CEO, Pres, Dir | A - Grant | $0.00 | +215.4K | 682.8K | +46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Units | 2024-01-23 | A | A | 563,499 | $0.00 | 1,852,119 | D | — | — | (F1) These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2024-01-23 | A | A | 215,405 | $0.00 | 682,811 | D | $3.14 · — to 2034-01-23 | 215,405 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 23, 2025, January 23, 2026 and January 23, 2027, subject to the Reporting Person's continued service. |